A Comparative Study of Tumor Specific Mesocolic Excision and Complete Mesocolic Excision for Right Sided Colon Cancer : Asian Multicenter Retrospective Study
1 other identifier
observational
3,326
1 country
1
Brief Summary
The goal of this observational study is to determine the optimal surgical strategy based on oncologic outcomes in patients with stage I-III right-sided colon cancer who underwent curative right hemicolectomy. The main question it aims to answer is: Is there a significant difference in 5-year recurrence-free survival (RFS) between patients treated with Complete Mesocolic Excision (CME) and those treated with tumor specific mesocolic excision (TSME)? Participants will include patients who underwent curative right hemicolectomy for right-sided colon cancer between 2015 and 2020 at eight institutions. They will be categorized into two groups based on the surgical technique received-CME group and TSME group-and evaluated for primary and secondary endpoints of 5-year recurrence-free survival (RFS) and overall survival (OS), respectively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2025
CompletedFirst Submitted
Initial submission to the registry
March 6, 2025
CompletedFirst Posted
Study publicly available on registry
March 10, 2025
CompletedMarch 10, 2025
March 1, 2025
6 years
March 6, 2025
March 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
5 year Recurrence free survival
Recurrence-Free Survival (RFS) between patients who underwent TSME and CME procedures from 2015 to 2020
Outcome measures will be assessed at 5 years post-surgery.
Secondary Outcomes (1)
Overall survival
Outcome measures will be assessed at 5 years post-surgery.
Study Arms (2)
Patients who underwent laparoscopic or robotic right hemicolectomy with CME from 2015 to 2020
Patients who underwent laparoscopic or robotic right hemicolectomy with Complete mesocolic excision from 2015 to 2020 in 8 centers
Patients who underwent with tumor specific mesocolic exicision from 2015 to 2020
Patients who underwent laparoscopic or robotic right hemicolectomy with tumor specific mesocolic exicision from 2015 to 2020 in 8 centers
Eligibility Criteria
This study included patients who underwent laparoscopic or robotic right hemicolectomy from 2015 to 2020 at 8 instituions : Asan Medical Center, Korea University Anam Hospital, Severance Hospital, Kyungpook National University Chilgok Hospital, Chinese University of Hong Kong, North District Hospital, Pamela Youde Nethersole Eastern Hospital, and China Medical University Hospital.
You may qualify if:
- Patients who underwent laparoscopic or robotic right hemicolectomy from 2015 to 2020
- Patients who received curative right hemicolectomy with lymphadenectomy
You may not qualify if:
- Familial adenomatous polyposis (FAP)
- Hereditary non-polyposis colon cancer (HNPCC)
- Patients with inflammatory bowel disease
- Patients with synchronous malignancies in other organs
- Patients with non-adenocarcinoma histology of colon cancer
- Patients with follow-up duration of less than 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Asan Medical Centerlead
- Korea University Anam Hospitalcollaborator
- Kyungpook National University Chilgok Hospitalcollaborator
- Severance Hospitalcollaborator
- Chinese University of Hong Kongcollaborator
- Pamela Youde Nethersole Eastern Hospitalcollaborator
- North District Hospitalcollaborator
- China Medical University Hospitalcollaborator
Study Sites (1)
Asan Medical Center
Seoul, Songpa, 05505, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 6, 2025
First Posted
March 10, 2025
Study Start
January 1, 2015
Primary Completion
December 31, 2020
Study Completion
January 15, 2025
Last Updated
March 10, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share